Cerebrospinal fluid dopamine in HIV-1 infection

AIDS

Volumn 8, Issue 1, 1994, Pages 67-71

  Berger, Joseph R ^a   Kumar, Mahendra ^a   Kumar, Adarsh ^a   Fernandez, Jesus B ^a   Levin, Bonnie ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Brain; Cerebrospinal fluid; Dopamine; HIV 1

Indexed keywords

CD4 ANTIGEN; DOPAMINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BASAL GANGLION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ARTICLE; DOPAMINERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; UNITED STATES;

EID: 0028328411     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199401000-00010     Document Type: Article

References (34)

1. NAVIA BA, JORDAN BD, PRICE RW: The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 19:517-524.
2. NAVIA BA, JORDAN BD, PRICE RW: The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525-535.
3. JANSSEN RJ, CORNBLATH DR, EPSTEIN LG, ET AL.: Nomenclature and research case definicitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 1991, 441:778-785.
4. PRICE RW, BREW B, SIDTIS J, ROSENBLUM M, SCHECK AC, CLEARY T: The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592.
5. MCHUGH PR, FOLSTEIN MF: Psychiatric syndromes of Huntingtons chorea: a clinical and phenomenologic study. In Psychiatric Aspects of Neurological Disease. Edited by Benson F, Blumer D. Grune and Stratton; New York: 1975.
6. BREW BJ, SIDTIS JJ, ROSENBLUM M, PRICE RW: AIDS dementia complex. J R Coll Physicians Lond 1988, 22:140-143.
7. KIEBURTZ KD, EPSTEIN LG, GELBARD HA, GREENAMYRE T: Excitotoxicity and dopaminergic dysfunction in the acquired immunodeficiency syndrome dementia complex: therapeutic implications. Arch Neurol 1991, 48:1281-1284.
8. NGUYEN N, RIMMER S, KATZ B: Slowed saccades in the acquired immunodeficiency syndrome. Amer J Ophthalmol 1989, 107:356-360.
9. CURRIE J, BENSON E, RAMSDEN B, PERDICES M, COOPER D: Eye movement abnormalities as a predictor of the acquired immunodeficiency syndrome dementia complex. Arch Neurol 1988, 45:949-953.
10. NATH A, JANKOVIC J, PETTIGREW LC: Movement disorders and AIDS. Neurology 1987, 37:37-41.
11. SINGER C, BERGER J, WEINER W, SANCHEZ-RAMOS J: Movement disorders in acquired immunodeficiency syndrome [abstract]. Movement Disorders 1991, 6:275.
12. HOLLANDER H, GOLDEN J, MENDELSON T, ET AL.: Extrapyramidal symptoms in AIDS patients given low-dose metoclopropamide or chlorpromazine [letter]. Lancet 1985, 2:1186.
13. HRISO E, KUHN T, MASDEU JC, GRUNDMAN M: Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy. Am J Psychiatry 1991, 11:1558-1561.
14. SWENSON JR, ERMAN M, LABELLE J, DIMSDALE JE: Extrapyramidal reactions: neuropsychiatric mimics in patients with AIDS. Gen Hosp Psychiatry 1989, 11:248-253.
15. EDELSTEIN H, KNIGHT RT: Severe parkinsonism in two AIDS patients taking prochlorperazine [letter]. Lancet 1987, 2:341-342.
16. CHASE TN, NG LKY: Central monoamine metabolism in Parkinson's disease. Arch Neurol 1972, 27:486-491.
17. ICHIKAWA N: Study on monamine metabolite contents of cerebrospinal fluid in patients with neurodegenerative diseases. Tohoku J Exp Med 1986, 150:435-446.
18. MAYEUX R, STERN Y: Intellectual dysfunction and dementia in Parkinson disease. Adv Neurol 1983, 38:211-227.
19. KORF J, VAN PRAAG HM, SCHUT D, NIENHUIS RJ, LAKKE JPWF: Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-dopa therapy. Eur Neurol 1974, 12:340-350.
20. LEWITT PA, GALLOWAY MP, MATSON W, ET AL.: Markers of dopamine metabolism in Parkinson's disease. Neurology 1992, 42:2111-2117.
21. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR: 'Mini-Mental State' method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
22. LEVIN B, BERGER JR, DIDONA T: Subtle cognitive decline in asymptomatic HIV-seropositive gay or bisexual men. Neuropsychology 1992, 6:303-313.
23. KUMAR M, MORGAN R, SZAPOCZNIK J, EISDROFER C: Norepinephrine response in early HIV infection. J Acquir Immune Defic Syndr 1991, 4:782-786.
24. KURE K, WEIDENHEIM DM, LYMAN WD, DICKSON DW: Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis: pattern of involvement resembling a multisystem degeneration. Acta Neuropathol 1990, 80:393-400.
25. REYES MG, FARALDI F, SENSENG S, FLOWERS C, PARIELLO R: Nigral degeneration in acquired immune deficiency syndrome (AIDS). Acta Neuropathol 1991, 82:39-44.
26. JAKOBSEN J, GYLDENSTED C, BRUN B, BRUHN P, HELWEG-LARSEN S, ARLIEN-SØBERG P: Cerebral ventricular enlargement related to neuropsychological measures in unselected AIDS patients. Acta Neurol Scand 1989, 79:59-62.
27. DAL PAN GJ, MCARTHUR JH, AYLWARD E, ET AL.: Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 1992, 42:2125-2130.
28. ROTTENBERG DA, MOELLER JR, STROTHER SC, ET AL.: The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987, 22:700-706.
29. VAN GORP WG, MANDELKERN MA, GEE M, ET AL.: Cerebral metabolic dysfunction in AIDS: findings in a sample with and without AIDS dementia. J Neuropsychiat Clin Neurosci 1992, 4:280-287.
30. LAFRANCE ND, PEARLSON GD, SCHAERF FW: I-123 IMP-SPECT in HIV-related dementia. Adv Funct Neuroimag 1988, 1:9-15.
31. KRAMER EL, SANGER JJ: Brain imaging in acquired immunodeficiency syndrome dementia complex. Semin Nucl Med 1990, 20:353-363.
32. BRITTON CB, COTE L, ALTSTIEL L: Cerebrospinal fluid biogenic amine metabolites in patients with AIDS (abstract). Neurology 1989, 39 (suppl):380.
33. LARSSON M, HAGBERG L, FORSMAN A, NORKRANS G: Monoaminergic transmitter systems during HIV infection. VII International Conference on AIDS. Florence, June 1991 [abstract MB2018].
34. BERGER JR, LEVY JA: The human immunodeficiency virus, type 1: the virus and its role in neurologic disease. Semin Neurol 1992, 12:1-9.